Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Platten

Showing results (221-230 of 318) with videos related to

Pageof 32
Sort By:
Neuro-Oncology|October 3, 2018
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastomaWolfgang Wick, Susan Dettmer, Anne Berberich, et al.
Neuro-Oncology|September 16, 2023
NLGN4X TCR transgenic T cells to treat gliomasChristoper Krämer, Michael Kilian, Yu-Chan Chih, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2017
Tweety-Homolog 1 Drives Brain Colonization of GliomasErik Jung, Matthias Osswald, Jonas Blaes, et al.
Neuro-Oncology|May 13, 2020
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trialMarianne Schell, Irada Pflüger, Gianluca Brugnara, et al.
Neuro-Oncology|July 9, 2026
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation NecrosisJohnny Duerinck, Martin Van Den Bent, Petter Brandal, et al.
Cancer Cell|January 13, 2023
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsMichael Kilian, Ron Sheinin, Chin Leng Tan, et al.
Elife|February 3, 2016
Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesisMichael O Breckwoldt, Julia Bode, Felix T Kurz, et al.
Journal for Immunotherapy of Cancer|October 17, 2022
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cellsNiklas Kehl, Michael Kilian, Julius Michel, et al.
Theranostics|November 1, 2023
<i>In vivo</i> nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental gliomaJessica Hunger, Katharina Schregel, Berin Boztepe, et al.
Nature Cancer|June 4, 2026
Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trialGhazaleh Tabatabai, Isabel Ramirez, Beatrix Welte, et al.
Pageof 32

Showing results (221-230 of 318) with videos related to

Sort By:
Pageof 32
Neuro-Oncology|October 3, 2018
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastomaWolfgang Wick, Susan Dettmer, Anne Berberich, et al.
Neuro-Oncology|September 16, 2023
NLGN4X TCR transgenic T cells to treat gliomasChristoper Krämer, Michael Kilian, Yu-Chan Chih, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2017
Tweety-Homolog 1 Drives Brain Colonization of GliomasErik Jung, Matthias Osswald, Jonas Blaes, et al.
Neuro-Oncology|May 13, 2020
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trialMarianne Schell, Irada Pflüger, Gianluca Brugnara, et al.
Neuro-Oncology|July 9, 2026
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation NecrosisJohnny Duerinck, Martin Van Den Bent, Petter Brandal, et al.
Cancer Cell|January 13, 2023
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsMichael Kilian, Ron Sheinin, Chin Leng Tan, et al.
Elife|February 3, 2016
Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesisMichael O Breckwoldt, Julia Bode, Felix T Kurz, et al.
Journal for Immunotherapy of Cancer|October 17, 2022
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cellsNiklas Kehl, Michael Kilian, Julius Michel, et al.
Theranostics|November 1, 2023
<i>In vivo</i> nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental gliomaJessica Hunger, Katharina Schregel, Berin Boztepe, et al.
Nature Cancer|June 4, 2026
Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trialGhazaleh Tabatabai, Isabel Ramirez, Beatrix Welte, et al.
Pageof 32